Fate Therapeutics (FATE) Return on Assets (2013 - 2026)

Fate Therapeutics' Return on Assets history runs 14 years deep, the most recent figure standing at 0.01% for Q1 2026.

• Quarterly Return on Assets rose 1.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (up 1.0% YoY) and the FY2025 annual result came in at 0.01%, changed 0.0% from the prior year.
• Return on Assets was 0.01% for Q1 2026 at Fate Therapeutics, down from 0.01% in the prior quarter.
• Across five years, Return on Assets topped out at 0.01% in Q1 2022 and bottomed at 0.02% in Q1 2025.
• A 5-year average of 0.01% and a median of 0.01% in 2023 frame the typical range for Return on Assets.
• Peak annual rise in Return on Assets reached 1 bps in 2025, while the deepest fall reached 1 bps in 2025.
• Fate Therapeutics' Return on Assets stood at 0.01% in 2022, then slipped by 26 bps to 0.02% in 2023, then sank by 30 bps to 0.02% in 2024, then soared by 51 bps to 0.01% in 2025, then fell by 3 bps to 0.01% in 2026.
• Business Quant data shows FATE's Return on Assets at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.02% in Q3 2025.